Invention Grant
- Patent Title: Detection and analysis method for urine-modified nucleoside based on surface-enhanced resonance Raman spectroscopy
-
Application No.: US16304691Application Date: 2016-09-18
-
Publication No.: US10935495B2Publication Date: 2021-03-02
- Inventor: Shangyuan Feng , Zuci Zheng , Qiwen Wang , Lan Wang , Duo Lin , Cuncheng Weng , Zufang Huang , Yongzeng Li , Rong Chen
- Applicant: Fujian Normal University
- Applicant Address: CN Fujian
- Assignee: Fujian Normal University
- Current Assignee: Fujian Normal University
- Current Assignee Address: CN Fujian
- Agency: JCIPRNET
- Priority: CN201610365125.3 20160527
- International Application: PCT/CN2016/099170 WO 20160918
- International Announcement: WO2017/201924 WO 20171130
- Main IPC: G01N21/65
- IPC: G01N21/65 ; G01N33/493

Abstract:
The present invention discloses a detection and analysis method for urine-modified nucleoside based on a surface-enhanced resonance Raman spectroscopy technology. In the method, a tumor marker modified nucleoside in the urine of a normal person and a cancer patient is extracted through the specificity of borophenylic acid gel; Au colloid is taken as an enhancing substrate to detect SERRS signals; and statistical analysis is conducted by using PLS-DA algorithms to establish a diagnosis and identification model for the SERRS of the urine-modified nucleoside. The model is used to discriminate that the to-be-detected urine-modified nucleoside belongs to the normal person or the cancer patient. After PLS-DA, the surface-enhanced resonance Raman spectroscopy data of the urine-modified nucleoside of the present invention has specificity of 96.9%, sensitivity of 98.2% and accuracy of 97.6%. The present invention has the characteristic of rapid and objective detection, and can provide important reference for doctors to diagnose esophagus cancer.
Public/Granted literature
Information query